These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10447140)

  • 1. Staphylococcal scalded skin syndrome: exfoliative toxin A (ETA) induces serine protease activity when combined with A431 cells.
    Ladhani S; Poston SM; Joannou CL; Evans RW
    Acta Paediatr; 1999 Jul; 88(7):776-9. PubMed ID: 10447140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus.
    Ladhani S
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):181-9. PubMed ID: 14625102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of staphylococcal exfoliative toxins on epidermal cell cultures and organotypic skin.
    Gentilhomme E; Faure M; Piemont Y; Binder P; Thivolet J
    J Dermatol; 1990 Sep; 17(9):526-32. PubMed ID: 1703553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin involvement in staphylococcal scalded skin syndrome.
    Lina G; Gillet Y; Vandenesch F; Jones ME; Floret D; Etienne J
    Clin Infect Dis; 1997 Dec; 25(6):1369-73. PubMed ID: 9431380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals.
    Nishifuji K; Sugai M; Amagai M
    J Dermatol Sci; 2008 Jan; 49(1):21-31. PubMed ID: 17582744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease.
    Vath GM; Earhart CA; Rago JV; Kim MH; Bohach GA; Schlievert PM; Ohlendorf DH
    Biochemistry; 1997 Feb; 36(7):1559-66. PubMed ID: 9048539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidermolytic toxins are serine proteases.
    Dancer SJ; Garratt R; Saldanha J; Jhoti H; Evans R
    FEBS Lett; 1990 Jul; 268(1):129-32. PubMed ID: 2384148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory mechanism for exfoliative toxin production in Staphylococcus aureus.
    Kato F; Kadomoto N; Iwamoto Y; Bunai K; Komatsuzawa H; Sugai M
    Infect Immun; 2011 Apr; 79(4):1660-70. PubMed ID: 21282415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.
    Yamaguchi T; Nishifuji K; Sasaki M; Fudaba Y; Aepfelbacher M; Takata T; Ohara M; Komatsuzawa H; Amagai M; Sugai M
    Infect Immun; 2002 Oct; 70(10):5835-45. PubMed ID: 12228315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1.
    Amagai M; Yamaguchi T; Hanakawa Y; Nishifuji K; Sugai M; Stanley JR
    J Invest Dermatol; 2002 May; 118(5):845-50. PubMed ID: 11982763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of detection systems for staphylococcal exfoliative toxin A responsible for scalded-skin syndrome.
    Ladhani S; Robbie S; Garratt RC; Chapple DS; Joannou CL; Evans RW
    J Clin Microbiol; 2001 Jun; 39(6):2050-4. PubMed ID: 11376033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution.
    Cavarelli J; Prévost G; Bourguet W; Moulinier L; Chevrier B; Delagoutte B; Bilwes A; Mourey L; Rifai S; Piémont Y; Moras D
    Structure; 1997 Jun; 5(6):813-24. PubMed ID: 9261066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in staphylococcal scalded skin syndrome.
    Ladhani S
    Clin Microbiol Infect; 2001 Jun; 7(6):301-7. PubMed ID: 11442563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inhibitor of Staphylococcus aureus exfoliative toxin.
    Al-Sulami AA; Al-Rubiay KK; Affat AM
    East Mediterr Health J; 2001; 7(1-2):121-7. PubMed ID: 12596961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.
    Amagai M; Matsuyoshi N; Wang ZH; Andl C; Stanley JR
    Nat Med; 2000 Nov; 6(11):1275-7. PubMed ID: 11062541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens.
    Plano LR; Gutman DM; Woischnik M; Collins CM
    Infect Immun; 2000 May; 68(5):3048-52. PubMed ID: 10769013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal exfoliative toxin induces caseinolytic activity.
    Takiuchi I; Kawamura M; Teramoto T; Higuchi D
    J Infect Dis; 1987 Sep; 156(3):508-9. PubMed ID: 2440955
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins.
    Yamasaki O; Yamaguchi T; Sugai M; Chapuis-Cellier C; Arnaud F; Vandenesch F; Etienne J; Lina G
    J Clin Microbiol; 2005 Apr; 43(4):1890-3. PubMed ID: 15815014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of protease from a mixture of exfoliative toxin and newborn-mouse epidermis.
    Ninomiya J; Ito Y; Takiuchi I
    Infect Immun; 2000 Sep; 68(9):5044-9. PubMed ID: 10948123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA).
    Rago JV; Vath GM; Bohach GA; Ohlendorf DH; Schlievert PM
    J Immunol; 2000 Feb; 164(4):2207-13. PubMed ID: 10657676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.